Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 2001

View Archived Issues

Desoxyepothilones B and F promising new cancer therapeutics

Vertex continues to advance broad clinical pipeline

Biogen's Amevive shows good results as therapy for psoriasis

Q2 2001 at Pharmacia marked by three E.U. approvals, making way for upcoming market launches

Human Genome Sciences' Albutropin and repifermin pass important milestones during Q2 2001

Regeneron's Axokine enters phase III trials

Results from pivotal phase III trials on Xanelim for psoriasis presented

Trinity Medical Group files NDA for Remune in Thailand

Major tea polyphenol attenuates neuronal cell death in vivo

Praecis updates clinical trial programs

Phase I safety study of RSD-1235 for atrial fibrillation reveals promising results

Results presented for rotigotine transdermal in early and advanced PD

FDA and NCI announce new clinical proteomics program

Phase III trial for HspE7 for anal dysplasia caused by HPV completes enrollment ahead of schedule

Cypress Bioscience to develop Pierre Fabre's milnacipran for chronic pain syndromes

Deltagen acquires Arcaris and extends functional proteomic research efforts

Second Genaera aminosterol compound induces weight loss in rodents

Comarketing agreement leads to quicker and more accurate gene analysis

New androgenic/progestational compounds described by Jenapharm

Derivatives useful as antiproliferative agents patented by Pfizer

Novel beta3-adrenoceptor agonists presented by GlaxoSmithKline

Ortho-McNeil reports new antibacterial derivatives

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...